Mustang Bio, Inc.
NASDAQ:MBIO
1.43 (USD) • At close September 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.823 | 2.225 | 3.031 | 2.306 | 1.785 | 1.368 | 0.63 | 0.002 | 0 | 0 |
| Gross Profit
| -0.823 | -2.225 | -3.031 | -2.306 | -1.785 | -1.368 | -0.63 | -0.002 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 7.557 | 39.18 | 63.949 | 53.539 | 45.624 | 36.315 | 24.464 | 20.376 | 8.547 | 4.044 |
| General & Administrative Expenses
| 4.135 | 9.686 | 12.21 | 11.017 | 9.505 | 9.57 | 6.759 | 11.409 | 2.816 | 0 |
| Selling & Marketing Expenses
| 0 | -0.365 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 4.135 | 9.321 | 12.21 | 11.017 | 9.505 | 9.57 | 6.759 | 11.409 | 2.816 | 0.254 |
| Other Expenses
| 0.038 | 0 | -3.031 | -0.139 | -0.108 | 0 | 3.36 | 0 | 0 | 0 |
| Operating Expenses
| 11.73 | 48.501 | 73.128 | 64.417 | 55.021 | 45.885 | 31.223 | 31.785 | 11.363 | 4.298 |
| Operating Income
| -16.245 | -50.726 | -76.159 | -66.723 | -56.806 | -45.885 | -31.223 | -31.785 | 11.363 | -4.298 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.493 | -0.876 | -1.366 | 0.353 | -3.209 | -0.504 | 0.561 | 0.497 | -24.017 | -0.168 |
| Income Before Tax
| -15.752 | -51.602 | -77.525 | -66.37 | -60.015 | -46.389 | -30.662 | -31.288 | -12.654 | -4.466 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -15.752 | -51.602 | -77.525 | -66.37 | -60.015 | -48.156 | -30.662 | -31.288 | -12.654 | -4.466 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -2.57 | -6 | -11.25 | -11.4 | -17.1 | -20.03 | -17.07 | -18.58 | -7.24 | -6.7 |
| EPS Diluted
| -2.57 | -6 | -11.25 | -11.4 | -17.1 | -20.03 | -17.07 | -18.58 | -7.24 | -6.7 |
| EBITDA
| -16.245 | -48.063 | -71.135 | -64.049 | -54.313 | -43.254 | -30.024 | -31.278 | -11.347 | -4.298 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |